Cullinan Therapeutics (CGEM) Retained Earnings (2020 - 2023)
Historic Retained Earnings for Cullinan Therapeutics (CGEM) over the last 4 years, with Q3 2023 value amounting to -$177.1 million.
- Cullinan Therapeutics' Retained Earnings fell 74662.17% to -$177.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$177.1 million, marking a year-over-year decrease of 74662.17%. This contributed to the annual value of -$47.7 million for FY2022, which is 6998.6% up from last year.
- According to the latest figures from Q3 2023, Cullinan Therapeutics' Retained Earnings is -$177.1 million, which was down 74662.17% from -$137.9 million recorded in Q2 2023.
- Over the past 5 years, Cullinan Therapeutics' Retained Earnings peaked at $3.9 million during Q2 2022, and registered a low of -$177.1 million during Q3 2023.
- In the last 4 years, Cullinan Therapeutics' Retained Earnings had a median value of -$107.4 million in 2021 and averaged -$103.1 million.
- Per our database at Business Quant, Cullinan Therapeutics' Retained Earnings soared by 10356.83% in 2022 and then crashed by 364333.08% in 2023.
- Over the past 4 years, Cullinan Therapeutics' Retained Earnings (Quarter) stood at -$93.3 million in 2020, then crashed by 70.25% to -$158.9 million in 2021, then soared by 69.99% to -$47.7 million in 2022, then crashed by 271.22% to -$177.1 million in 2023.
- Its Retained Earnings was -$177.1 million in Q3 2023, compared to -$137.9 million in Q2 2023 and -$105.7 million in Q1 2023.